Cite Filings / APRE / 0001493152-26-003971

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Aprea Therapeutics, Inc. Filed 2026-01-28 Acc 0001493152-26-003971

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-02 4 President/CEO bought 28,100 shares at $0.89 ($25,009)
2026-02-02 4 SrVP/CFO/Prin Fin & Acct Ofcr bought 5,700 shares at $0.89 ($5,073)
2026-01-29 8-K Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
2026-01-28 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-01-23 8-K Delisting notice
2025-11-12 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…